I think this case will be an exception. Walmart values its pharmaceutical business as a transactional commodity, like much of the rest of its business. That s

I think this case will be an exception. Walmart values its pharmaceutical business as a transactional commodity, like much of the rest of its business. That said the primary concern is increasing quantity of transactions opposed to rate of return. They are willing to lose money in the short term on price depreciating generic drug offerings provided that people will continue to consume those drugs well into the future. This is part of the solution to a problem of over-night skyrocketing drug prices from unethical drug companies. If that such model can be effectively applied to low-cost health insurance for low-income people then the country is much better for it.